Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Cell membrane disruption is associated with numerous diseases and underlies the activity of various antimicrobial agents. The rapid screening of compounds capable of disrupting or permeabilizing biological membranes is essential to the search for new therapeutic drugs. Here, we present a single-molecule confocal microscopy assay integrated with fast-flow microfluidics to study membrane permeabilization in large unilamellar vesicles (LUVs) containing as few as seven dye molecules. This assay eliminates the need for liposome immobilization and achieves detection rates in the range of 1000 vesicles per minute, offering unparalleled sensitivity and detection limits as low as 135 pM, corresponding to just eight permeabilizing molecules per vesicle for active compounds such as ionomycin. It provides a robust platform for investigating membrane-disrupting agents, including those with antimicrobial properties or implicated in neurodegenerative diseases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184303 | PMC |
http://dx.doi.org/10.1002/anie.202503678 | DOI Listing |